FEIST, Eugen, BARALIAKOS, Xenofon, BEHRENS, Frank, THAÇI, Diamant, KLOPSCH, Thilo, PLENSKE, Anja, BLINDZELLNER, Lisa K., KLAUS, Pascal, MENG, Thomas und LÖSCHMANN, Peter-Andreas, 2022. Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. [Erscheinungsort nicht ermittelbar]: Springer Healthcare.
Elsevier - Harvard (with titles)Feist, E., Baraliakos, X., Behrens, F., Thaçi, D., Klopsch, T., Plenske, A., Blindzellner, L.K., Klaus, P., Meng, T., Löschmann, P.-A., 2022. Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes, Rheumatology and therapy. Springer Healthcare, [Erscheinungsort nicht ermittelbar]. https://doi.org/10.1007/s40744-021-00418-5
American Psychological Association 7th editionFeist, E., Baraliakos, X., Behrens, F., Thaçi, D., Klopsch, T., Plenske, A., Blindzellner, L. K., Klaus, P., Meng, T., & Löschmann, P.-A. (ca. 2022). Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes [Cd]. In Rheumatology and therapy. Springer Healthcare. https://doi.org/10.1007/s40744-021-00418-5
Springer - Basic (author-date)Feist E, Baraliakos X, Behrens F, Thaçi D, Klopsch T, Plenske A, Blindzellner LK, Klaus P, Meng T, Löschmann P-A (2022) Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes. Springer Healthcare, [Erscheinungsort nicht ermittelbar]
Juristische Zitierweise (Stüber) (Deutsch)Feist, Eugen/ Baraliakos, Xenofon/ Behrens, Frank/ Thaçi, Diamant/ Klopsch, Thilo/ Plenske, Anja/ Blindzellner, Lisa K./ Klaus, Pascal/ Meng, Thomas/ Löschmann, Peter-Andreas, Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes, [Erscheinungsort nicht ermittelbar] 2022.